Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial

by Schuind, Anne, Segall, Nathan, Drame, Mamadou, Innis, Bruce L.
Published 2015

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

by Madan, Anuradha, Segall, Nathan, Ferguson, Murdo, Frenette, Louise, Kroll, Robin, Friel, Damien, Soni, Jyoti, Li, Ping, Innis, Bruce L., Schuind, Anne
Published 2016

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial

by Ramanakumar, Agnihotram V, Naud, Paulo, Roteli-Martins, Cecilia M, de Carvalho, Newton S, de Borba, Paola C, Teixeira, Julio C, Blatter, Mark, Moscicki, Anna-Barbara, Harper, Diane M, Romanowski, Barbara, Tyring, Stephen K, Ramjattan, Brian, Schuind, Anne, Dubin, Gary, Franco, Eduardo L
Published 2016